Diagnosis 2017-06-22T16:43:37+00:00


Radiological Diagnostic Methods (The First Step Towards Accurate Treatment)

Accurate radiological diagnosis is an essential part of deciding how treatment should be performed. Modern techniques and advanced technology are of paramount importance when performing radiological diagnosis, as well as an experienced radiology staff.

Accurate radiological diagnosis is crucial in deciding whether the cancer needs treatment or not. As well as qualified radiology staff, it is essential that techniques applied with advanced technology are used in accurate diagnosis. ACIBADEM Healthcare Group, working according to this principle and closely following developments in medical science, is constantly changing its diagnostic equipment in all ACIBADEM hospitals and outpatient centers with new high-tech equipment. ACIBADEM Hospitals Group offers diagnosis and treatment services to patients using latest technology equipment, and radiology specialists work together with well-trained and experienced radiology technicians and nurses.


Cutting-Edge Technology in Diagnostics:


For rapid and reliable diagnosis

The PET/CT device is used to identify tumors in their early stages, particularly for cancer treatment, and to determine whether these tumors are malign or benign. The device is also used in the diagnosis and treatment of neurological and cardiological disorders.

Pet/CT In Early Diagnosis

PET/CT offers many significant advantages in early diagnosis. It offers the opportunity to identify many disorders at the beginning phase. In pre-PET/CT periods, it was determined only by biopsy whether nodules in the body are cancerous or not, whereas now it is determined at a high rate of precision with PET/CT.

In PET/CT imaging, it is possible to visualize tumors as small as 5 mm in diameter, as information taken from the patient’s body images is obtained through advanced computer systems. PET/CT, by taking advantage of increased glucose metabolism, a feature of cancerous cells, facilitates establishment of fast and reliable diagnosis without taking any samples.

PET/CT In Metastasis

PET/CT also offers a significant advantage for the determination of whether the disease spread to adjacent tissues or lymph nodes in many cancer types, i.e. whether there is metastasis or not. Since the entire body is visualized at the same time thanks to the images taken via PET/CT, it is also possible to evaluate whether the cancer has spread to another organ. Thus, PET/CT is highly advantageous in determining, for instance, whether a tumor in the lung has spread to other internal organs, the adrenal glands or the lymph nodes (whether there is metastasis or not), in other words for determining the extensity of the disorder which is known as staging.

PET/CT Is Performed At 6 ACIBADEM Hospitals

ACIBADEM Maslak ACIBADEM Kozyatağı ACIBADEM Kadıköy, International Hospital ACIBADEM , Adana ACIBADEM , Bursa ACIBADEM Kocaeli.

An imaging technology which is only used at ACIBADEM Kozyatağı Hospital in Turkey, Intraoperative MR facilitates the complete removal of the tumor by providing images during brain surgery. It thus eliminates the risk of a second operation that would be required, due to tumor residues.

Advantages of 3-Tesla MRI:

Generates more robust information than low-Tesla systems

The 3-Tesla MRI device generates faster data with higher resolution during and after the operation, and provides physicians with more reliable information than that obtained from low-Tesla MRI systems. The device achieves this thanks to its strong magnetic field. By generating a magnetic field twice as strong as the magnetic field of the 1.5-Tesla MRI device, which had been used previously, it receives more signals from tissues.

Works more rapidly

The 3-Tesla MRI device works much quicker than other devices. This is especially important during brain surgery. The system allows the surgeon to take images during the operation at any required moment without waking the patient and without closing the surgical area. In particular, it addresses surgeons’ concerns about obtaining correct information on the size and direction of the tumor if it is in a place difficult to reach. The chances of operational success improve as images may be evaluated during the operation.

Eliminates the risk of a second operation

Various risks may arise in operations in which intraoperative MRI is not used. In these operations, residues cannot be identified due to the fact that they are so small that they cannot be seen with a microscope, or they are of the same color as the brain tissue. As such, there is a 30-40% probability of residues being left over in brain tumor operations. The patient is taken into intensive care after the operation. Whether or not residues are present may be determined based on MRI images taken 24 hours after the period of intensive care. In the event that any residues are identified in the MRI, a second operation will take place. Here, thanks to its intraoperative feature a second operation is not required as residues may be fully identified and removed during the operation.

Zero probability of residues

Thanks to the 3-Tesla MRI device, there is no chance of residues being left in the brain after the operation. All residues that may be omitted are identified with the images the device takes. Thus, the surgeon has reliable information when it comes to removing these residues as well. One of the worst results of leaving residues is that the tumor may grow again from these residues. The growing tumor may compromise the patient’s quality of life or even threaten the patient’s life again. Another satisfactory result of the complete removal of the tumor is that it further delays the recurrence of malign brain tumors.

Accurate identification of operation area

Operation-related side effects are eliminated.

A mammography device which delivers excellent two- and three-dimensional image quality at the lowest required dose. With its two dimensional and multi slice three dimensional tomosynthetic imaging capacity, it offers groundbreaking possibilities in the early diagnosis of cancer.